Synthaverse SA
WSE:SVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Synthaverse SA
WSE:SVE
|
PL |
|
H
|
HIVE Blockchain Technologies Ltd
F:HBF
|
CA |
|
Uttam Sugar Mills Ltd
NSE:UTTAMSUGAR
|
IN |
|
G
|
Great Southern Copper PLC
LSE:GSCU
|
UK |
|
Flomic Global Logistics Ltd
BSE:504380
|
IN |
|
H
|
Hoang Quan Consulting Trading Service Real Estate Corp
VN:HQC
|
VN |
|
N
|
NVIDIA Corp
XETRA:NVD
|
US |
|
N
|
Ningbo Bohui Chemical Technology Co Ltd
SZSE:300839
|
CN |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
US |
|
Titan Company Ltd
NSE:TITAN
|
IN |
|
Suvidhaa Infoserve Ltd
NSE:SUVIDHAA
|
IN |
|
Saratoga Investment Corp
NYSE:SAR
|
US |
|
P
|
PTL Enterprises Ltd
NSE:PTL
|
IN |
|
TBS Holdings Inc
TSE:9401
|
JP |
|
Conduit Holdings Ltd
LSE:CRE
|
BM |
|
Kiromic Biopharma Inc
OTC:KRBP
|
US |
|
Provexis PLC
LSE:PXS
|
UK |
|
Moog Inc
NYSE:MOG.A
|
US |
|
C Rad AB
STO:CRAD B
|
SE |
|
Granges AB
STO:GRNG
|
SE |
|
Sunlight Real Estate Investment Trust
HKEX:435
|
HK |
|
Jiangsu Jingxue Insulation Technology Co Ltd
SZSE:301010
|
CN |
|
Kabra Extrusion Technik Ltd
NSE:KABRAEXTRU
|
IN |
|
W
|
Wegmans Holdings Berhad
KLSE:WEGMANS
|
MY |
Multiples-Based Value
The Multiples-Based Value of one SVE stock under the Base Case scenario is hidden PLN. Compared to the current market price of 3.68 PLN, Synthaverse SA is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SVE Competitors Multiples
Synthaverse SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
S
|
Synthaverse SA
WSE:SVE
|
260.4m PLN | 4.8 | -43 | 31.2 | -150.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |